Clinical trials recruiting in Stendal, Germany

Phase breakdown

Conditions recruiting in Stendal, Germany

Recruiting trials in Stendal, Germany

• A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer at High Risk of Recurrence
  NCT06830720 · Phase: Not specified · Ages: 18 Years to 100 Years · Sex: All (male and female)
• NeoAdj. Therapy Comparing Sacituzumab Govitecan (SG) vs. SG+Pembrolizumab in Low-risk, Triple-neg. EBC (ADAPT-TN-III)
  NCT06081244 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Female
• NeoRad Breast Cancer Study
  NCT04261244 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Female

Common questions

How many clinical trials are recruiting in Stendal, Germany?

3 recruiting trials have at least one study site in Stendal, Germany.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.